🇺🇸 FDA
Patent

US 11426415

Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders

granted A61KA61K31/155A61K31/4178

Quick answer

US patent 11426415 (Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/155, A61K31/4178, A61K31/4985, A61K31/554